General meetings shall be held in Lund, Stockholm or Malmö. Notice convening the annual general meetings and extraordinary general meetings where amendments to the articles of association are to be addressed, shall be issued no earlier than six weeks and no later than four weeks prior to the meeting. Notice convening other extraordinary general meetings shall be issued no earlier than six weeks and no later than three weeks prior to the meeting. Notice shall be published in periodicals and domestic newspapers and by making the notice available on the company’s website. Information regarding the notice shall at the same time be advertised in Svenska Dagbladet.
Proposals to the General Meeting should be addressed to SynAct Pharma AB, Att: Legal, Scheelevägen 2, SE-223 63 Lund, Sweden or by email to [email protected]synactpharma.com and submitted no later than seven weeks prior to the Annual General Meeting, or in any case, if required, in time for the matter to be included in the notice convening the Annual General Meeting.